Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    oxalate

    ACTIVE PHARMA INGREDIENTS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 605Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tonix Announces Issuance of U.S. Patent for and Uses of Tianeptine Oxalate
    Tonix Announces Issuance of U.S. Patent for and Uses of Tianeptine Oxalate

    19 Mar 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/03/19/2196082/0/en/Tonix-Pharmaceuticals-Announces-Issuance-of-U-S-Patent-for-Compositions-and-Uses-of-Tianeptine-Oxalate-Salt-the-Active-Ingredient-of-TNX-601-CR.html

    GLOBENEWSWIRE
    19 Mar 2021
    Share Share
    Dicerna’s nedosiran achieves urinary oxalate normalisation in PH trial
    Dicerna’s nedosiran achieves urinary oxalate normalisation in PH trial

    23 Oct 2020

    // CLINICALTRAILSARENA

    https://www.clinicaltrialsarena.com/news/dicerna-nedosiran-urinary-oxalate/

    CLINICALTRAILSARENA
    23 Oct 2020
    Share Share
    Alnylam preps next filing as rare kidney disease med aces phase 3
    Alnylam preps next filing as rare kidney disease med aces phase 3

    18 Dec 2019

    // A. Al Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/alnylam-preps-next-filing-as-rare-kidney-disease-med-aces-phase-3

    A. Al Idrus FIERCE BIOTECH
    18 Dec 2019
    Share Share
    BeeVital GmbH VarroMed Receives Approval In Europe
    BeeVital GmbH VarroMed Receives Approval In Europe

    10 Apr 2017

    // EMA

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004016/human_med_002088.jsp&mid=WC0b01ac058001d124

    EMA
    10 Apr 2017
    Share Share